Skip to main content
SpringerLink
Log in

Denosumab nell’iperparatiroidismo primitivo

  • PARATIROIDI E METABOLISMO CALCIO FOSFORO
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Leere JL, Karmisholt J, Robaczyk M, Vestergaard P (2017) Contemporary medical management of primary hyperparathyroidism: a systematic review. Front Neuroendocrinol 8:79

    Article  Google Scholar 

  2. Eller-Vainicher C, Palmieri S, Cairoli E et al. (2018) Protective effect of Denosumab on bone in older women with primary hyperparathyroidism. J Am Geriatr Soc 66(3):518–524

    Article  Google Scholar 

  3. Rajan R, Cherian KE, Kapoor N, Paul TV (2019) Denosumab as a bridge to surgery in a patient with severe hypercalcemia due to primary hyperparathyroidism in the setting of renal dysfunction. Indian J Endocrinol Metab 23(2):269–270

    Article  Google Scholar 

  4. Konrade I, Dambrova G, Dambrova M (2017) Denosumab-induced hypophosphataemia in a case of normocalcaemic primary hyperparathyroidism. Int Med J 47(8):974–975

    Article  Google Scholar 

  5. Jumpertz von Schwartzenberg R, Elbelt U, Ventz M et al. (2015) Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy. Endocrinol Diabetes Metab Case Rep 2015:150082

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Ciniche e di Comunità, Università degli Studi di Milano, Milano, Italia

    Giorgia Grassi

  2. Unità di Endocrinologia, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Milano, Italia

    Giorgia Grassi & Cristina Eller Vainicher

Authors
  1. Giorgia Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Eller Vainicher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Eller Vainicher.

Ethics declarations

Conflitto di interesse

Le autrici Giorgia Grassi e Cristina Eller Vainicher dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Le autrici di questo articolo non hanno eseguito studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grassi, G., Eller Vainicher, C. Denosumab nell’iperparatiroidismo primitivo. L'Endocrinologo 21 (Suppl 1), 42–44 (2020). https://doi.org/10.1007/s40619-020-00708-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00708-0

Search

Navigation